What's in CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.'s pipeline?

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. has 9 drugs in our index: 0 marketed, 0 filed, 5 in Phase 3, 3 in Phase 2, 1 in Phase 1.

Which companies overlap with CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: Pfizer, GlaxoSmithKline, Sanofi, HK inno.N Corporation, Eli Lilly and Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/cspc-baike-shandong-biopharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. pipeline: 0 marketed, 0 filed, 5 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 5 Phase 3 3 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
HD1916	HD1916	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
Placebo of CM326	Placebo of CM326	phase 3
Omalizumab for injection	Omalizumab for injection	phase 3	Monoclonal antibody	IgE	Immunology
SYN008	SYN008	phase 3	PD-1 inhibitor	PD-1	Oncology
TG103	TG103	phase 3			Oncology

Therapeutic area mix

Diabetes · 2
Oncology · 2
Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Pfizer · 4 shared drug classes
GlaxoSmithKline · 4 shared drug classes
Sanofi · 4 shared drug classes
HK inno.N Corporation · 3 shared drug classes
Eli Lilly and Company · 3 shared drug classes
Merck Sharp & Dohme LLC · 3 shared drug classes
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · 3 shared drug classes
Daewoong Pharmaceutical Co. LTD. · 3 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/cspc-baike-shandong-biopharmaceutical-co-ltd. Accessed 2026-05-18.